B

Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315

Watchlist Manager
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Watchlist
Price: 8.25 HKD -2.02%
Market Cap: 3.3B HKD
Have any thoughts about
Biocytogen Pharmaceuticals Beijing Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Biocytogen Pharmaceuticals Beijing Co Ltd

Current Assets 766.1m
Cash & Short-Term Investments 419.9m
Receivables 192.7m
Other Current Assets 153.6m
Non-Current Assets 1.7B
Long-Term Investments 179.3m
PP&E 1.4B
Intangibles 24.4m
Other Non-Current Assets 67.5m
Current Liabilities 572.6m
Accounts Payable 117.8m
Accrued Liabilities 23.8m
Other Current Liabilities 431m
Non-Current Liabilities 1.1B
Long-Term Debt 328.6m
Other Non-Current Liabilities 791.4m

Balance Sheet
Biocytogen Pharmaceuticals Beijing Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
697
466
603
418
Cash
697
466
603
418
Short-Term Investments
200
100
8
8
Total Receivables
82
118
112
148
Accounts Receivables
67
103
108
142
Other Receivables
15
15
4
6
Inventory
62
83
95
89
Other Current Assets
107
106
101
77
Total Current Assets
1 148
874
919
723
PP&E Net
1 136
1 391
1 599
1 451
PP&E Gross
1 136
1 391
1 599
1 451
Accumulated Depreciation
105
225
367
514
Intangible Assets
2
6
31
28
Long-Term Investments
10
10
198
188
Other Long-Term Assets
31
22
53
59
Total Assets
2 327
N/A
2 303
-1%
2 800
+22%
2 449
-13%
Liabilities
Accounts Payable
88
102
146
175
Accrued Liabilities
29
59
40
25
Short-Term Debt
0
0
0
0
Current Portion of Long-Term Debt
14
27
172
203
Other Current Liabilities
198
259
248
174
Total Current Liabilities
328
447
606
578
Long-Term Debt
67
63
244
341
Deferred Income Tax
0
0
0
2
Minority Interest
5
5
5
5
Other Liabilities
473
541
799
739
Total Liabilities
873
N/A
1 056
+21%
1 654
+57%
1 664
+1%
Equity
Common Stock
360
375
399
399
Retained Earnings
126
644
1 228
1 580
Additional Paid In Capital
1 219
1 516
1 992
1 992
Other Equity
0
1
17
26
Total Equity
1 453
N/A
1 247
-14%
1 146
-8%
786
-31%
Total Liabilities & Equity
2 327
N/A
2 303
-1%
2 800
+22%
2 449
-13%
Shares Outstanding
Common Shares Outstanding
397
397
399
399

See Also

Discover More